Agios Pharmaceuticals Inc banner

Intrinsic Value

The intrinsic value of Agios Pharmaceuticals Inc (8AP) under the Base Case is 39.38 EUR per share. Compared with the current market price of 27 EUR, the stock appears Undervalued by 31% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

8AP Intrinsic Value
€39.38
Undervaluation 31%
Intrinsic Value
Price €27
Alert me when 8AP is below its intrinsic value
Today €23.63 · 12.5% below the current price

8AP is cheaper than usual. This is its cheapest valuation in the past 5 years.

Alternatives to 8AP

Fundamental Analysis

What Agios Pharmaceuticals Does

Biotechnology Health Care

Agios Pharmaceuticals is a biotech company that develops medicines for rare blood disorders. Its main approved drug is Pyrukynd, a pill used to treat certain inherited anemia conditions by helping red blood cells make energy more efficiently. The company also keeps working on other drug candidates in rare hematology, using the same idea of targeting cell metabolism.

Headquarters
United States of America US
Employees
539
IPO date
Jul 24, 2013
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · November 5, 2026

Agios paired record third-quarter product revenue with a launch-ready sickle cell franchise, while an FDA major amendment moved the PDUFA goal date to February 1, 2027.

Open the earnings call
EPS
−$1.09
Expected
−$1.32
Surprise
+17.4%
Stock, day of the call
−9.9%
View Earnings Call

Agios Pharmaceuticals insiders are selling within their usual range

Insider trading · Last trade on Oct 26, 2026

Sold $3.6m 7 insiders
Bought $0 Nobody bought
Trades by date
Open insider trading

Past 12 months

Continue 8AP Research

Decided on Agios Pharmaceuticals? Get an email when 8AP reaches the price you’d buy at. Free with an account.

Other Agios Pharmaceuticals listings

What is the Intrinsic Value of one 8AP stock?

The intrinsic value for Agios Pharmaceuticals Inc (8AP) under the Base Case is 39.38 EUR.

Is 8AP stock undervalued or overvalued?

Compared with the current market price of 27 EUR, the stock appears Undervalued by 31% .

How reliable are our estimates? See how past valuations played out
Back to Top